Jonathan Weiss/ Shuttershock

11 June 2024Big PharmaMarisa Woutersen

Court orders Teva to remove asthma patents from Orange Book

Victory for Amneal Pharmaceuticals as court dismisses infringement claims | Decision orders Teva to remove patents covering its breathing drug from the FDA's Orange Book | Paves the way for Amneal's generic version.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

McGuireWoods expands team with ex-Novo Nordisk GC

UPC bans Meril Life Sciences from selling infringing heart valve

SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic

Kathi Vidal to rejoin previous firm as partner following USPTO departure

GSK triumphs in EPO appeal, revoking Pfizer patent

‘We took Ravgen head-on’: How we won zero-damages and others didn't

Bristol Myers Squibb leader named INTA 2025 president

Kathi Vidal to leave USPTO ahead of incoming Trump administration